BCR-ABL/GATA1/miR-138 mini circuitry contributes to the leukemogenesis of chronic myeloid leukemia
Authors:
Open Access
- 3 December 2012
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 33 (1) , 44-54
Abstract
Abnormal expression of microRNAs (miRNAs) has been implicated in carcinogenesis. Here we report a novel BCR (breakpoint cluster region)-ABL (c-abl oncogene 1, non-receptor tyrosine kinase)/GATA1/microRNA-138 (miR-138) circuitry in chronic myeloid leukemia (CML). miR-138 expression is downregulated in K562 cells and primary CML samples, which is restored after imatinib treatment. The tumor suppressor activity of miR-138 is demonstrated by the induction of cell cycle arrest at G0/G1, inhibition of cell proliferation and colony forming unit granulocyte-macrophage colony formation and enhanced imatinib-induced apoptosis in K562 and Ku812 cells overexpressing miR-138. Moreover, overexpression of miR-138 led to the downregulation of BCR-ABL. Based on luciferase assay, ABL and BCR-ABL are shown to be the target genes regulated by miR-138. Furthermore, miR-138 binding to ABL was shown to localize to the coding region instead of 3′-untranslated regions (3′-UTR) of ABL mRNA. In addition, CCND3 is another target of miR-138, which represses CCND3 expression by binding to its 3′-UTR. Finally, upregulation of miR-138 upon imatinib treatment is associated with the enhancement of GATA1 activity, which binds to the miR-138 promoter. In conclusion, miR-138 is a tumor suppressor miRNA underexpressed in CML. miR-138 represses expression of both BCR-ABL and CCND3 via binding to the coding region and 3′-UTR, respectively. miR-138 expression is activated by GATA1, which in turn is repressed by BCR-ABL. Therefore, miR-138, by virtue of a BCR-ABL/GATA1/miR-138 circuitry, is a tumor suppressor miRNA implicated in the pathogenesis of CML and its clinical response to imatinib.Keywords
This publication has 41 references indexed in Scilit:
- MicroRNA-193b regulates proliferation, migration and invasion in human hepatocellular carcinoma cellsEuropean Journal of Cancer, 2010
- MicroRNAs and their target gene networks in breast cancerBreast Cancer Research, 2010
- SnapShot: MicroRNAs in CancerCell, 2009
- MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma #Hepatology, 2009
- MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiationNature, 2008
- miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemiaBrazilian Journal of Medical and Biological Research, 2007
- MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemiaOncogene, 2007
- MicroRNA in Lung CancerJournal of Thoracic Oncology, 2006
- Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissuesMolecular Cancer, 2006
- MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma CellsCancer Research, 2005